Drug discovery

384-well microplate
#Assays #Aurora Microplates #Drug development #Drug discovery #Lab technology #Preclinical development

How the tools you use impact consistency and precision in the lab

The latest sponsored DDW Sitting Down With podcast features Charles Powell, CEO of Aurora Microplates, discussing how the microplate has evolved to keep up with changing trends within research and development. The microplate is a seemingly simple tool, yet it has a crucial role to play… Read More

#Podcasts

#Artificial intelligence (AI) #Cell and gene therapy #Drug discovery #Generative AI

Can vertical AI advance cell and gene therapies? 

Andrew Busey, Co-Founder, Form Bio, discusses why vertical AI is set to reshape the cell and gene therapy sector. The once-fictional artificial intelligence (AI) depicted in literature and movies has transitioned into a tangible and easily accessible tool in our modern world. General AI tools such as ChatGPT have… Read More

#Exclusive Content

#Drug development #Drug discovery #Guide #Human disease models #Mouse models #Pharmokinetics

HuPK: A Humanised Platform for therapeutic antibody PK evaluation

Download the guide to learn more about:   How JAX’s HuPK™ Humanised FcRn Platform offers a validated and cost-effective solution for assessing the in vivo  preclinical pharmacokinetics and stability of Fc-based biologics and therapeutics carried by albumin.    JAX’s… Read More

#Intelligence #Resources

#Alzheimer's #Cancer research #Cell therapy #CRISPR #Drug discovery #Parkinson's #Plant-based #Stem cells

New DDW Highlights podcast: 4 December 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The key drug discovery news this week focuses on experimental approaches to… Read More

#News

#Alzheimer's #Cancer research #Cell therapy #CRISPR #Drug discovery #Parkinson's #Plant-based #Stem cells

This week in drug discovery (27 Nov – 1 Dec) 

News round-up for 27 November – 1 December by DDW Digital Content Editor Diana Spencer. The key drug discovery news this week focuses on experimental approaches to the treatment of some of the most challenging diseases, including a mathematical model that can simulate Alzheimer’s progression and… Read More

#News

#Drug delivery #Drug development #Drug discovery #Drug repurposing #Microbiome #Mucoadhesive drug delivery #Pharmaceutical industry #Synthetic biology

New podcast: Outside the box thinking for drug discovery success

This is the latest episode of the free DDW narrated podcast, “Outside the box thinking for drug discovery success”, which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Stanford researchers construct the most complete synthetic microbiome, … Read More

#News

PEGS Europe posters
#Antibodies #Antibody discovery workflow #Biologics #Drug discovery #Events #PEGS Europe 2023 #Protein engineering

Reflecting on PEGS Europe 2023 

DDW’s Megan Thomas attended PEGS Europe 2023 in Lisbon, Portugal, from Tuesday 14 November to Thursday 16 November 2023. Here, she shares insight from the annual biologics technology meeting.   Scientific tracks and presentations  Antibody-based cancer therapies   The first presentation attended in the antibody-based cancer therapies… Read More

#Exclusive Content

New appointments
#Appointment #Drug discovery #New appointment

Drug discovery’s senior appointments for Q4

Keep up to speed with the sector’s top executive appointments with DDW’s regular recruitment round-up. Kimryn Rathmell  has been chosen as the 17th director of the National Cancer Institute (NCI), bringing her experience as leader of the Department of Medicine at the Vanderbilt University Medical Center… Read More

#News

Flower of Oldenlandia monanthos
#Drug discovery #Plant-based #Proteins #University of Bath

Can a plant-based discovery pave the way for new drug treatments?

Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. This new tool may help researchers develop new pharmaceuticals in a cleaner, greener, and less expensive way. Drug treatments often… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cloud computing #Drug discovery #Machine learning

Future-proofing drug discovery through flexible platforms

Dr Robert Scoffin, CEO, and Tim Cheeseright, Chief Technology Officer, at Cresset, explore the importance of flexible solutions for future-proofing drug discovery.  The ability to respond to changes in patient and customer needs is a constant challenge in the pharmaceutical industry, with ever-evolving requirements influencing even… Read More

#Exclusive Content

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

DDW eBook: The latest innovations in cell and gene therapy

Hailed as a revolution in the treatment of many diseases, cell and gene therapy is the fastest growing area of therapeutics. This eBook, ‘Cell & Gene Therapy: The advances and innovation’, provides a comprehensive overview of the latest innovations in cell and gene therapies, where the… Read More

#News

#Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

Cell & Gene Therapy: The advances and innovation

This 24-page eBook sponsored by Sartorius explores the latest innovations in cell and gene therapies, where the challenges lie and the possible solutions to overcoming these obstacles. Download this free resource to learn more about: The ways cell and gene therapies (CGTs) are revolutionising medicine in a range of diseases How… Read More

#DDW eBooks #Intelligence

Target concept
#Biopharma #Covid-19 #Drug discovery

The value of mission-orientated research in biopharma R&D 

Patrick Speedie, Co-Founder & Co-CEO of IN-PART, explores why a global approach is needed for the best science to prosper and the lessons industry can take from the Covid-19 pandemic.    The Covid-19 pandemic unequivocally demonstrated the power of industry-academia collaboration, with the fastest ever… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Big pharma #BioNTech #Biopharmaceuticals #Comirnaty #Covid-19 #Drug discovery #Healthcare #Moderna #mRNA #Pfizer

New podcast on drug discovery trends

This is the latest episode of the free DDW narrated podcast, “Drug discovery trends: From regulation to embracing AI”, which covers two articles written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: From the Editor: Law and order and… Read More

#News

#AI #Biotech #Drug discovery #Generative AI

Genentech and NVIDIA partner to accelerate drug discovery with AI 

Biotechnology company Genentech has entered into a partnership with software group NVIDIA to use generative AI to discover and develop new therapeutics.   The collaboration will see experts from each company optimise and accelerate Genentech’s proprietary algorithms with goals to transform the discovery and development of new… Read More

#News